{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:17:46Z","timestamp":1768270666520,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002630","name":"Ewha Womans University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2020R1A2C1009224"],"award-info":[{"award-number":["2020R1A2C1009224"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2023R1A2C1004720"],"award-info":[{"award-number":["2023R1A2C1004720"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["21153MFDS601-1"],"award-info":[{"award-number":["21153MFDS601-1"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcrc.2023.154402","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:51:55Z","timestamp":1692964315000},"page":"154402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia"],"prefix":"10.1016","volume":"78","author":[{"given":"Sung Wook","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong Geun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeoul","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungwon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy Jeong","family":"Rhie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyoung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2023.154402_bb0005","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.2147\/IDR.S383285","article-title":"Prevalence of multidrug-resistant pathogens causing bloodstream infections in an intensive care unit","volume":"15","author":"Golli","year":"2022","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.jcrc.2023.154402_bb0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/cid\/ciab696","article-title":"Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States","volume":"74","author":"Nelson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2023.154402_bb0015","author":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)"},{"key":"10.1016\/j.jcrc.2023.154402_bb0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkab499","article-title":"Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"77","author":"Hanai","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0025","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/jac\/dkx289","article-title":"Pharmacodynamics of teicoplanin against MRSA","volume":"72","author":"Ramos-Mart\u00edn","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FTD.0b013e3180690755","article-title":"Variability in teicoplanin protein binding and its prediction using serum albumin concentrations","volume":"29","author":"Yano","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jcrc.2023.154402_bb0035","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.10-2371","article-title":"Antibiotic dosing in multiple organ dysfunction syndrome","volume":"139","author":"Ulldemolins","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2023.154402_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijantimicag.2014.01.023","article-title":"Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI study","volume":"43","author":"Roberts","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2023.154402_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccc.2020.08.006","article-title":"The effect of aging physiology on critical care","volume":"37","author":"Darden","year":"2021","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jcrc.2023.154402_bb0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2023.154402_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211015573","article-title":"Augmented renal clearance: a retrospective, cohort study of urinary creatinine clearance in critically ill patients in the United Kingdom","volume":"49","author":"Johnston","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jcrc.2023.154402_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance","volume":"49","author":"Udy","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1515\/jtim-2015-0010","article-title":"Clinical conundrums in management of sepsis in the elderly","volume":"3","author":"Sehgal","year":"2015","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.jcrc.2023.154402_bb0070","first-page":"12","article-title":"Epidemiology of hypoalbuminemia in hospitalized patients: a clinical matter or an emerging public health problem?","author":"Moramarco","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jcrc.2023.154402_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjsurg.2015.06.013","article-title":"Hypoalbuminemia at admission is associated with increased incidence of in-hospital complications in geriatric trauma patients","volume":"212","author":"Garwe","year":"2016","journal-title":"Am J Surg"},{"key":"10.1016\/j.jcrc.2023.154402_bb0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/cid\/civ360","article-title":"Critical care medicine and infectious ciseases: an emerging combined subspecialty in the United States","volume":"61","author":"Kadri","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2023.154402_bb0085","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/cc11471","article-title":"Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study","volume":"16","author":"Mongardon","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154402_bb0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","article-title":"Timing of antibiotic therapy in the ICU","volume":"25","author":"Kollef","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154402_bb0095","author":"The United Nations Refugee Agency (UNHCR)"},{"key":"10.1016\/j.jcrc.2023.154402_bb0100","author":"Ministry of Food and Drug Safety (MFDS)"},{"key":"10.1016\/j.jcrc.2023.154402_bb0105","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.3399\/bjgp18X695993","article-title":"Application of prescribing recommendations in older people with reduced kidney function: a cross-sectional study in general practice","volume":"68","author":"Wood","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jcrc.2023.154402_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jcrc.2023.154402_bb0115","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics13040572","article-title":"Quantification of teicoplanin using the HPLC-UV method for clinical applications in critically ill patients in Korea","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcrc.2023.154402_bb0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jcph.505","article-title":"Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients","volume":"55","author":"Chung","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154402_bb0125","first-page":"650","article-title":"Gentamicin therapy","volume":"8","author":"Devine","year":"1974","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jcrc.2023.154402_bb0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.107009","article-title":"Predictive value of hypoalbuminemia and severe hypoalbuminemia in oncologic spine surgery","volume":"210","author":"Gelfand","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jcrc.2023.154402_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.26","article-title":"Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance","volume":"2","author":"Byon","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154402_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.jcrc.2023.154402_bb0150","first-page":"15","article-title":"Pharmacokinetic\/pharmacodynamic analysis of teicoplanin in patients with MRSA infections","volume":"8","author":"Matsumoto","year":"2016","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jcrc.2023.154402_bb0155","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"10.1016\/j.jcrc.2023.154402_bb0160","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/jac\/dkx242","article-title":"Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen","volume":"72","author":"Cazaubon","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00003088-198712040-00003","article-title":"Teicoplanin pharmacokinetics in patients with chronic renal failure","volume":"12","author":"Bonati","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0170","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1128\/AAC.40.5.1242","article-title":"Population pharmacokinetic study of teicoplanin in severely neutropenic patients","volume":"40","author":"Lortholary","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"674","key":"10.1016\/j.jcrc.2023.154402_bb0175","first-page":"e7","article-title":"Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic\/pharmacodynamic targets in adult patients with haematological malignancy","volume":"23","author":"Byrne","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcrc.2023.154402_bb0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijantimicag.2015.03.010","article-title":"Changes in the pharmacokinetics of teicoplanin in patients with hyperglycaemic hypoalbuminaemia: impact of albumin glycosylation on the binding of teicoplanin to albumin","volume":"46","author":"Enokiya","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2023.154402_bb0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jiac.2017.12.002","article-title":"Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function","volume":"24","author":"Kasai","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003088-200443060-00004","article-title":"Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages","volume":"43","author":"Pea","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/FTD.0000000000000906","article-title":"Population pharmacokinetics of teicoplanin and its dosing recommendations for neutropenic patients with augmented renal clearance for hematological malignancies","volume":"43","author":"Sako","year":"2021","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jcrc.2023.154402_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cpdd.684","article-title":"Population pharmacokinetics and pharmacodynamics of teicoplanin and C-reactive protein in hospitalized patients with gram-positive infections","volume":"9","author":"Ogami","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jcrc.2023.154402_bb0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/clpt.1990.87","article-title":"The pharmacokinetics of teicoplanin in varying degrees of renal function","volume":"47","author":"Lam","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jcrc.2023.154402_bb0210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dkx473","article-title":"Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy","volume":"73","author":"Byrne","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jcrc.2023.154402_bb0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"39","author":"Wilson","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0220","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","article-title":"Pharmacokinetics and dosage adjustment in patients with renal dysfunction","volume":"65","author":"Verbeeck","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2023.154402_bb0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000321857","article-title":"A quantitative approach to drug dosing in chronic kidney disease","volume":"31","author":"Olyaei","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.jcrc.2023.154402_bb0230","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkg147","article-title":"Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose","volume":"51","author":"Pea","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0235","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s10096-019-03652-6","article-title":"Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy","volume":"38","author":"Kim","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcrc.2023.154402_bb0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/FTD.0000000000000498","article-title":"Measurement of teicoplanin concentration with liquid chromatography-tandem mass spectrometry method demonstrates the usefulness of therapeutic drug monitoring in hematologic patient populations","volume":"40","author":"Chae","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jcrc.2023.154402_bb0245","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3349\/ymj.2011.52.4.616","article-title":"Teicoplanin dosing strategy for treatment of Staphylococcus aureus in Korean patients with neutropenic fever","volume":"52","author":"Ahn","year":"2011","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jcrc.2023.154402_bb0250","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40262-017-0623-4","article-title":"Clinical pharmacokinetics and pharmacodynamics of telavancin compared with the other glycopeptides","volume":"57","author":"al Jalali","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2023.154402_bb0255","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2215\/CJN.08140718","article-title":"Clinical pharmacology of antibiotics","volume":"14","author":"Eyler","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jcrc.2023.154402_bb0260","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmell","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2023.154402_bb0265","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.00951-13","article-title":"Protein binding of \u03b2-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?","volume":"57","author":"Wong","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412300151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412300151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:43Z","timestamp":1760125963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412300151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":53,"alternative-id":["S088394412300151X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154402","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154402"}}